Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome.

Stanley TL, Zanni MV, Johnsen S, Rasheed S, Makimura H, Lee H, Khor VK, Ahima RS, Grinspoon SK.

J Clin Endocrinol Metab. 2011 Jan;96(1):E146-50. doi: 10.1210/jc.2010-1170. Epub 2010 Nov 3.

2.

On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate.

Williamson RT.

Br Med J. 1901 Mar 30;1(2100):760-2. No abstract available.

3.

Association between fine particulate matter and diabetes prevalence in the U.S.

Pearson JF, Bachireddy C, Shyamprasad S, Goldfine AB, Brownstein JS.

Diabetes Care. 2010 Oct;33(10):2196-201. doi: 10.2337/dc10-0698. Epub 2010 Jul 13.

4.

Thirty-one novel biomarkers as predictors for clinically incident diabetes.

Salomaa V, Havulinna A, Saarela O, Zeller T, Jousilahti P, Jula A, Muenzel T, Aromaa A, Evans A, Kuulasmaa K, Blankenberg S.

PLoS One. 2010 Apr 9;5(4):e10100. doi: 10.1371/journal.pone.0010100.

5.

The effects of weight loss and gastric banding on the innate and adaptive immune system in type 2 diabetes and prediabetes.

Viardot A, Lord RV, Samaras K.

J Clin Endocrinol Metab. 2010 Jun;95(6):2845-50. doi: 10.1210/jc.2009-2371. Epub 2010 Apr 7.

PMID:
20375213
6.

The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.

Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE; TINSAL-T2D (Targeting Inflammation Using Salsalate in Type 2 Diabetes) Study Team.

Ann Intern Med. 2010 Mar 16;152(6):346-57. doi: 10.7326/0003-4819-152-6-201003160-00004.

8.

Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT).

Kahn SE, Haffner SM, Viberti G, Herman WH, Lachin JM, Kravitz BG, Yu D, Paul G, Holman RR, Zinman B; Diabetes Outcome Progression Trial (ADOPT) Study Group.

Diabetes Care. 2010 Jan;33(1):177-83. doi: 10.2337/dc09-1661. Epub 2009 Oct 6.

9.

Statin therapy and risk of developing type 2 diabetes: a meta-analysis.

Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai N, Alderman M, Ridker PM.

Diabetes Care. 2009 Oct;32(10):1924-9. doi: 10.2337/dc09-0738.

10.

Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial.

Pradhan AD, Everett BM, Cook NR, Rifai N, Ridker PM.

JAMA. 2009 Sep 16;302(11):1186-94. doi: 10.1001/jama.2009.1347.

PMID:
19755697
11.

The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease.

Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, Offenbacher S, Ridker PM, Van Dyke TE, Roberts WC; American Journal of Cardiology; Journal of Periodontology.

Am J Cardiol. 2009 Jul 1;104(1):59-68. doi: 10.1016/j.amjcard.2009.05.002. No abstract available.

PMID:
19576322
12.

Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes.

Goldfine AB, Silver R, Aldhahi W, Cai D, Tatro E, Lee J, Shoelson SE.

Clin Transl Sci. 2008 May;1(1):36-43. doi: 10.1111/j.1752-8062.2008.00026.x.

13.

Nuclear factor-{kappa}B activation contributes to vascular endothelial dysfunction via oxidative stress in overweight/obese middle-aged and older humans.

Pierce GL, Lesniewski LA, Lawson BR, Beske SD, Seals DR.

Circulation. 2009 Mar 10;119(9):1284-92. doi: 10.1161/CIRCULATIONAHA.108.804294. Epub 2009 Feb 23.

14.

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group.

N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.

15.

Salicylates increase insulin secretion in healthy obese subjects.

Fernández-Real JM, López-Bermejo A, Ropero AB, Piquer S, Nadal A, Bassols J, Casamitjana R, Gomis R, Arnaiz E, Pérez I, Ricart W.

J Clin Endocrinol Metab. 2008 Jul;93(7):2523-30. doi: 10.1210/jc.2007-1212. Epub 2008 May 6.

PMID:
18460568
16.

The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus.

Donath MY, Mandrup-Poulsen T.

Nat Clin Pract Endocrinol Metab. 2008 May;4(5):240-1. doi: 10.1038/ncpendmet0783. Epub 2008 Mar 4. No abstract available.

17.
18.

Salsalate improves glycemia and inflammatory parameters in obese young adults.

Fleischman A, Shoelson SE, Bernier R, Goldfine AB.

Diabetes Care. 2008 Feb;31(2):289-94. Epub 2007 Oct 24.

19.

Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study.

Rana JS, Boekholdt SM, Ridker PM, Jukema JW, Luben R, Bingham SA, Day NE, Wareham NJ, Kastelein JJ, Khaw KT.

J Intern Med. 2007 Dec;262(6):678-89. Epub 2007 Oct 1.

20.

Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis.

Wasko MC, Hubert HB, Lingala VB, Elliott JR, Luggen ME, Fries JF, Ward MM.

JAMA. 2007 Jul 11;298(2):187-93.

PMID:
17622600

Supplemental Content

Support Center